当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3571133
已选条件
-
T11071Dofequidar fumarateMS-209
Dofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1.
价 格:¥电议型 号:T11071产 地:中国大陆
-
T11071Dofequidar fumarateDofequidar fumarate,MS-209,
It has been reported that an orally active quinoline compound, dofenacid fumarate (MS-209 fumarate), can overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-related protein 1 or both. IC50 value: Target: In vitro P-gp: 3 microM MS-209 effectively overcomes d
价 格:¥电议型 号:T11071产 地:美洲
-
T26854BMS641;化合物BMS641BMS-641|||BMS-209641|||BMS 641;BMS-641|||BMS-209641|||BMS 641
BMS641 (BMS-209641) is a selective and potent RARβ agonist.BMS641 has a high affinity for RARβ and synergistically activates RARβ and RARgamma to induce cellular maturation into specialized neuronal subtypes.
价 格:¥电议型 号:T26854产 地:中国大陆
-
T11071Dofequidar fumarate;化合物Dofequidar fumarateMS-209;MS-209
Dofequidar fumarate (MS-209)(MS-209 fumarate), a quinoline-based compound administered orally, is known for counteracting multidrug resistance (MDR) through the inhibition of ABCB1/P-glycoprotein (P-gp) and ABCC1/MDR-associated protein 1.
价 格:¥电议型 号:T11071产 地:中国大陆